Howard Matthew, Jones Michael, Clarkson Richard, Donaldson Oliver
Department of Trauma and Orthopaedics, Yeovil District Hospital, Yeovil, UK.
Shoulder Elbow. 2022 Apr;14(2):157-161. doi: 10.1177/1758573220968454. Epub 2020 Oct 25.
Pectoralis minor syndrome involves pain, paraesthesia and weakness in the arm due to compression of the brachial plexus passing beneath pectoralis minor; this paper reports the results of a single centre's treatment pathway in affected patients.
During a four-year period, patients exhibiting symptoms of pectoralis minor syndrome without significant improvement following physiotherapy proceeded to Botulinum injection. Those with good response to injection but subsequent recurrence of symptoms were offered pectoralis minor tenotomy. Oxford shoulder Scores were collected at baseline and after interventions.
Twenty-one patients received Botulinum injection; at six weeks following injection, mean change in Oxford Shoulder Score was +12.4, with only one patient reporting a worsening of symptoms. Of the 17 patients with clinically significant response to injection, 12 have subsequently undergone tenotomy; three months following tenotomy, mean change in Oxford Shoulder Score from baseline was +22.3. Improvement was maintained in all patients at prolonged follow-up (average 20 months post-tenotomy).
This pathway has shown to be extremely effective in patients not responding to first-line treatment for pectoralis minor syndrome, with 85% of patients post-injection and 100% of patients post-tenotomy showing significant (greater than published minimal clinically important difference value of six points) improvements in Oxford Shoulder Score, maintained at follow-up.
胸小肌综合征是由于臂丛神经在胸小肌下方受到压迫,导致手臂出现疼痛、感觉异常和无力;本文报告了一个单一中心对受影响患者的治疗方案结果。
在四年期间,表现出胸小肌综合征症状且物理治疗后无明显改善的患者接受肉毒杆菌注射。对注射有良好反应但随后症状复发的患者接受胸小肌切断术。在基线和干预后收集牛津肩部评分。
21例患者接受了肉毒杆菌注射;注射后六周,牛津肩部评分的平均变化为+12.4,只有1例患者报告症状恶化。在对注射有临床显著反应的17例患者中,12例随后接受了切断术;切断术后三个月,牛津肩部评分相对于基线的平均变化为+22.3。在长期随访(切断术后平均20个月)中,所有患者的改善情况均得以维持。
该治疗方案已证明对胸小肌综合征一线治疗无反应的患者极为有效,注射后85%的患者以及切断术后100%的患者在牛津肩部评分上有显著改善(大于已发表的最小临床重要差异值6分),且在随访中得以维持。